1920P ImmunoDriver-2: CD8 T cell and PD-L1 levels associate with first-line (1L) overall survival (OS) in immune checkpoint inhibition (ICI)-treated non-small cell lung cancer (NSCLC)

Authors

J Lee
B Rhead
E B. Garon
J W. Goldman
M Velez
A Gower
A E. Lisberg
P Boutros
S M. Dubinett
E Williams
U Jariwala
C Hegarty-Traverso
S Fragkogianni
Michael A. Thompson, Advocate Health - MidwestFollow
J Mercer
A L. Cummings

Recommended Citation

Lee JM, Rhead B, Garon EB, et al. 1920P ImmunoDriver-2: CD8 T cell and PD-L1 levels associate with first-line (1L) overall survival (OS) in immune checkpoint inhibition (ICI)-treated non-small cell lung cancer (NSCLC). Annals of Oncology. 2025 September;36:S1097-S1098. doi:10.1016/j.annonc.2025.08.2544

Document Type

Abstract